Scinovex
article Open AccessTop 1% cited

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial

Annals of Surgical Oncology · 2011 · Vol. 18(6) · pp. 1575–1581
Xiaojun YangChaoqun HuangTao SuoLie-Jun MeiGuoliang YangFulin ChengYunfeng ZhouBin XiongYutaka YonemuraYan Li

Abstract

For synchronous gastric PC, CRS + HIPEC with mitomycin C 30 mg and cisplatin 120 mg may improve survival with acceptable morbidity.

Intraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentNeuroendocrine Tumor Research AdvancesMedicineHyperthermic intraperitoneal chemotherapySurgical oncologyRandomized controlled trialSurgeryPeritoneal carcinomatosisConfidence intervalClinical endpointCancerAdverse effect

MeSH terms

AdenocarcinomaAdultAgedAntineoplastic Combined Chemotherapy ProtocolsAdenocarcinoma, MucinousCarcinoma, Squamous CellCisplatinCombined Modality TherapyFemaleHumansHyperthermia, InducedInjections, IntraperitonealMaleMiddle AgedNeoplasm Staging

Funding

  • National Natural Science Foundation of China
  • Science Fund for Creative Research Groups
Citations
679
FWCI
32.71
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.